辣木叶次生代谢产物的分离、合成及对CYP3A4和CYP2D6的抑制作用
本研究从辣木叶中分离鉴定出1个新化合物omoringone及12个已知次生代谢产物,并合成了omoringone和niazirin。所有分离物在50 µM以下对测试细胞株无细胞毒性,提取物抑制CYP3A4(IC50=52.5 ± 2.5 µg/ml),化合物1-4和7-9抑制CYP3A4(IC50=41.5-100 µM),对CYP2D6无明显影响。
要点
- 辣木叶提取物及部分分离物在体外抑制CYP3A4,提示潜在草药-药物相互作用。
- 分离物在50 µM以下未显示细胞毒性。
- 化合物对CYP2D6无明显抑制,CYP3A4抑制需关注临床相关性。
核心结论
- 辣木叶提取物及分离的化合物1-4和7-9在体外抑制CYP3A4,对CYP2D6无明显影响,提示需进一步研究其草药-药物相互作用潜力。
研究设计与样本
- 体外实验:从辣木叶中分离鉴定次生代谢产物,通过波谱分析确定结构,并评估细胞毒性和对CYP3A4、CYP2D6的抑制作用。
主要发现
- 分离得到1个新化合物omoringone(1)和12个已知次生代谢产物(2-13),属于黄酮类、萜类、木脂素类和苯丙素类。
- 所有分离物在50 µM浓度下对SK-MEL、KB、BT-549、SK-OV-3、VERO、LLC-PK1和HepG2细胞株均无细胞毒性。
- 辣木叶提取物抑制CYP3A4,IC50 = 52.5 ± 2.5 µg/ml。
- 化合物1-4和7-9抑制CYP3A4,IC50范围为41.5至100 µM,对CYP2D6无明显影响。
关键数值与推荐
- CYP3A4抑制:提取物IC50 = 52.5 ± 2.5 µg/ml;化合物1-4和7-9的IC50范围为41.5-100 µM。
- 细胞毒性:所有分离物在50 µM浓度下对测试细胞株无细胞毒性。
临床怎么用
- 中医及中西医结合医生应关注辣木叶及其成分与CYP3A4底物药物的潜在相互作用,避免联用风险。
局限性
- 研究为体外实验,未评估植物化学物的生物利用度,需进一步在生理相关条件下验证临床相关性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Moringa oleifera Lam. is known as a drumstick tree that is widely cultivated in various subtropical and tropical provinces. Previous studies indicated that both aqueous and methanolic extracts of M. oleifera leaves have potent inhibitory effects on two major drug metabolizing Cytochrome P450 enzymes, namely, CYP3A4 and CYP2D6. PURPOSE: The current study was aimed to isolate the secondary metabolites from M. oleifera and investigate their cytotoxicity and inhibitory effects on CYP3A4 and CYP2D6 to assess their herb-drug interaction (HDI) potential. METHODS: Chemical structure elucidation was achieved by interpreting the spectroscopic data (UV, IR, 1D, and 2D NMR experiments), confirming by HR-ESI-MS, and comparing with the previously reported data in the literature. All the isolates were evaluated for their cytotoxicity against a panel of cell lines (SK-MEL, KB, BT-549, SK-OV-3, VERO, LLC-PK1, and HepG2) and inhibition of two principal CYP isozymes (CYP3A4 and CYP2D6). RESULTS: Phytochemical investigation of M. oleifera leaves resulted in the isolation and characterization of one new compound, namely omoringone (1), along with twelve known secondary metabolites (2-13) belonging to several chemical classes including flavonoids, terpenoids, lignans, and phenylalkanoids. A plausible biosynthetic pathway for compound 1 was provided. Because of the low isolation yield and limited supply, omoringone (1) and niazirin (12) were successively synthesized. No cytotoxicity was observed on any of the tested cell lines up to 50 µM. The extract exhibited an inhibitory effect on CYP3A4 isoform (IC50 = 52.5 ± 2.5 µg/ml). Among the isolates, 1-4 and 7-9 inhibited CYP3A4 with the IC50 values ranging from 41.5 to 100 µM with no remarkable effect on CYP2D6 isozyme. CONCLUSION: This work aided in ascertaining components of M. oleifera contributing to CYP3A4 inhibition exhibited by the extract using an in vitro assay. Nonetheless, further studies are warranted to determine the bioavailability of the phytochemicals and extrapolate these findings in more physiologically relevant conditions to further establish the clinical relevance of in vitro observations.
引用
- Fantoukh OI, Albadry MA, Parveen A, et al. Isolation, synthesis, and drug interaction potential of secondary metabolites derived from the leaves of miracle tree (Moringa oleifera) against CYP3A4 and CYP2D6 isozymes. Phytomedicine. 2019. PMID: 31301970. doi:10.1016/j.phymed.2019.153010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。